These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2914599)

  • 21. The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA.
    Colaco CB; Elkon KB
    Arthritis Rheum; 1985 Jan; 28(1):67-74. PubMed ID: 3917672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of lupus anticoagulant and anti-DNA binding in patients with systemic lupus erythematosus.
    Bennett RE; Calabrese LH; Lucas FV; Clough JD
    Cleve Clin Q; 1985; 52(2):115-8. PubMed ID: 3928199
    [No Abstract]   [Full Text] [Related]  

  • 23. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus.
    Gårdlund B
    Acta Med Scand; 1984; 215(4):293-8. PubMed ID: 6428168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the lupus anticoagulant.
    Espinoza LR; Hartmann RC
    Am J Hematol; 1986 Jul; 22(3):331-7. PubMed ID: 3087160
    [No Abstract]   [Full Text] [Related]  

  • 25. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant in women with multiple spontaneous miscarriage.
    Howard MA; Firkin BG; Healy DL; Choong SC
    Am J Hematol; 1987 Oct; 26(2):175-8. PubMed ID: 3116842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.
    Gastineau DA; Kazmier FJ; Nichols WL; Bowie EJ
    Am J Hematol; 1985 Jul; 19(3):265-75. PubMed ID: 3925759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.
    Asherson RA; Mackay IR; Harris EN
    Br Heart J; 1986 Aug; 56(2):190-3. PubMed ID: 3089242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus anticoagulant and pregnancy.
    Lubbe WF; Liggins GC
    Am J Obstet Gynecol; 1985 Oct; 153(3):322-7. PubMed ID: 3931480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
    Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
    J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.
    Rosove MH; Ismail M; Koziol BJ; Runge A; Kasper CK
    Blood; 1986 Aug; 68(2):472-8. PubMed ID: 3730611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
    BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study on evaluation of circulating anticoagulant in borderline cases].
    Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-prothrombin antibodies and the lupus anticoagulant.
    Fleck RA; Rapaport SI; Rao LV
    Blood; 1988 Aug; 72(2):512-9. PubMed ID: 2456797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
    Rote NS; Dostal-Johnson D; Branch DW
    Am J Obstet Gynecol; 1990 Aug; 163(2):575-84. PubMed ID: 2117391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lupus anticoagulant: an increasingly used marker].
    Castañeda Sanz S; Herrero-Beaumont G; Tornero Molina J; Aguado García JM; Outeiriño J
    Rev Clin Esp; 1985 Jun; 177(1):1-6. PubMed ID: 3929341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.